Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT00120523

Public ClinicalTrials.gov record NCT00120523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to investigate the safety of pimecrolimus cream 1% in the long-term treatment (up to 5 years) of atopic dermatitis (eczema) in patients less than 12 months of age compared to topical corticosteroids (TCS).

Study identification

NCT ID
NCT00120523
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDA Pharma GmbH & Co. KG
Industry
Enrollment
2,418 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Months to 12 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Feb 11, 2022

2004 – 2010

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016 —
Cholla Pediatrics Tucson Arizona 85741 —
Arkansas Pediatric Clinic Little Rock Arkansas 72205 —
Little Rock Allergy & Asthma Clinic Little Rock Arkansas 72205 —
9540 Artesia Blvd., Suite #1 Bellflower California 90706 —
Pediatric Care Medical Group, Inc. Huntington Beach California 92647 —
Longmont Clinical Research Longmont Colorado 80501 —
Children's Skin Center Miami Florida 33155 —
Pediatric Research Center of South Florida Palm Beach Gardens Florida 33458 —
AeroAllergy Research Laboratories of Savanah, Inc. Savannah Georgia 31406 —
The Pediatric Center Stone Mountain Georgia 30083 —
Wayne State University Dermatology Detroit Michigan 48201 —
Michigan State University - Kalamazoo Center for Med Studies Kalamazoo Michigan 49008 —
Respiratory Medicine Research Institute of Michigan Ypsilanti Michigan 48197 —
SMDC Health System Duluth Minnesota 55805 —
Dermatology Center for Children Minneapolis Minnesota 55404 —
University of Minnesota - Dept. of Dermatology Minneapolis Minnesota 55455 —
Radiant Research Bridgeton Missouri 63044 —
Dermatology Associates of Rochester, P.C. Rochester New York 14623 —
Capitol Pediatrics & Adolescent Center Raleigh North Carolina 27609 —
Dermatology Research Associates Cincinnati Ohio 245230 —
Ohio Pediatrics, Inc. Huber Heights Ohio 45424 —
The Portland Clinic Beaverton Oregon 97006 —
Calcagno Research and Development Gresham Oregon 97030 —
Allergy & Asthma Consultants, LLP Charleston South Carolina 29414 —
Allergic Disease and Asthma Center Greenville South Carolina 29607 —
University of Tennessee - Dept. of Pediatrics Memphis Tennessee 38105 —
Suzanne Bruce& Associates, PA Houston Texas 77056 —
Grand Parkway Pediatrics Sugar Land Texas 77479 —
Virginia Commonwealth University Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00120523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2022 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00120523 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →